The complete directory of every peptide, research compound, and blend in the catalog. Search by name, check the research stage reached so far, and open a full profile with its verified sources. Looking to explore by topic instead? Browse research categories.
107 results
Individual peptide
Muscle signaling, performance, and post-exercise recovery pathways under study.
Evidence Review Pending
Level 3 · Early Human Research
Early human trials were run then discontinued for safety reasons.
Evidence Review Pending
Level 1 · Laboratory Research
Laboratory and computational work only.
Evidence Review Pending
Level 2 · Animal Research
Animal obesity studies; human development halted.
Individual peptide
Skin, hair, pigmentation, collagen, and extracellular-matrix pathways under study.
Evidence Review Pending
Level 1 · Laboratory Research
Cell and tissue studies of copper-peptide signaling.
Evidence Review Pending
Level 2 · Animal Research
Animal exercise-mimetic studies; human use restricted in sport.
Other research compound
Cardiac, vascular, circulation, and blood-flow pathways under study.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Approved prostaglandin therapy in urology and neonatal care.
Evidence Review Pending
Level 4 · Controlled Human Studies
Randomized human trials conducted for obesity; results were modest.
Individual peptide
Muscle signaling, performance, and post-exercise recovery pathways under study.
Evidence Review Pending
Level 4 · Controlled Human Studies
Randomized controlled trials in neuropathic pain and sarcoidosis.
Other research compound
Cognition, mood, focus, and neural signaling pathways under study.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Approved for multiple therapeutic and cosmetic indications.
Blend · 2 components
Research interest in this blend centres on lean-tissue maintenance and training-recovery pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Blend · 3 components
Researchers are studying this blend in relation to muscle signaling and post-exercise recovery pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Blend · 4 components
Researchers are studying this blend in relation to muscle signaling and post-exercise recovery pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Blend · 4 components
Researchers are studying this blend in relation to muscle signaling and post-exercise recovery pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Individual peptide
Muscle signaling, performance, and post-exercise recovery pathways under study.
Evidence Review Pending
Level 2 · Animal Research
Extensive rodent studies; no completed controlled human trials.
Blend · 3 components
Research interest in this blend centres on lean-tissue maintenance and training-recovery pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Blend · 2 components
Research interest in this blend centres on lean-tissue maintenance and training-recovery pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Individual peptide
Immune signaling, host defense, and inflammatory-response pathways under study.
Evidence Review Pending
Level 1 · Laboratory Research
Laboratory bioregulator work only.
Individual peptide
Appetite, glucose, metabolic, and energy-balance pathways under study.
Evidence Review Pending
Level 4 · Controlled Human Studies
Randomized controlled trials alone and with semaglutide.
Blend · 2 components
This blend is examined in studies of nutrient handling and body-composition pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Evidence Review Pending
Level 2 · Animal Research
Animal and cell bioregulator studies from a limited research group.
Individual peptide
Joint, tendon, ligament, connective-tissue, and repair pathways under study.
Evidence Review Pending
Level 1 · Laboratory Research
Laboratory bioregulator work only.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Registered and clinically used for neurological conditions in several countries.
Individual peptide
Gastrointestinal, mucosal, pancreatic, and digestive signaling under study.
Evidence Review Pending
Level 1 · Laboratory Research
Laboratory bioregulator work only.
Individual peptide
Appetite, glucose, metabolic, and energy-balance pathways under study.
Evidence Review Pending
Level 3 · Early Human Research
Small early human pharmacology studies of growth hormone release.
Individual peptide
Appetite, glucose, metabolic, and energy-balance pathways under study.
Evidence Review Pending
Level 3 · Early Human Research
Small early human pharmacology studies; limited clinical data.
Blend · 2 components
Researchers are studying this blend in relation to appetite signaling and glucose regulation.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Evidence Review Pending
Level 2 · Animal Research
Animal and cell bioregulator studies from a limited research group.
Evidence Review Pending
Level 1 · Laboratory Research
Laboratory bioregulator work only.
Evidence Review Pending
Level 2 · Animal Research
Animal opioid-receptor research only.
Evidence Review Pending
Level 3 · Early Human Research
Small, older human sleep and pain studies; little modern replication.
Individual peptide
Appetite, glucose, metabolic, and energy-balance pathways under study.
Evidence Review Pending
Level 3 · Early Human Research
Early-phase human trials underway; no controlled outcome data published yet.
Evidence Review Pending
Level 3 · Early Human Research
Small human studies, largely from a single research group.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Approved erythropoiesis-stimulating agent in clinical use.
Individual peptide
Mitochondrial function, cellular energy, and metabolic resilience under study.
Evidence Review Pending
Level 1 · Laboratory Research
Cell-model senescence research only.
Individual peptide
Mitochondrial function, cellular energy, and metabolic resilience under study.
Evidence Review Pending
Level 1 · Laboratory Research
Cell and tissue studies without the copper complex.
Individual peptide
Mitochondrial function, cellular energy, and metabolic resilience under study.
Evidence Review Pending
Level 4 · Controlled Human Studies
Controlled topical skin trials plus extensive laboratory work.
Other research compound
Appetite, glucose, metabolic, and energy-balance pathways under study.
Evidence Review Pending
Not yet reviewed
No editorial evidence review has been published for this profile yet.
Blend · 2 components
Researchers are studying this blend in relation to gastrointestinal signaling and mucosal pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Blend · 2 components
This blend is examined in studies of gastric, intestinal, and pancreatic pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Individual peptide
Appetite, glucose, metabolic, and energy-balance pathways under study.
Evidence Review Pending
Level 3 · Early Human Research
Early human growth hormone secretagogue studies.
Individual peptide
Appetite, glucose, metabolic, and energy-balance pathways under study.
Evidence Review Pending
Level 3 · Early Human Research
Early human growth hormone secretagogue studies.
Other research compound
Mitochondrial function, cellular energy, and metabolic resilience under study.
Evidence Review Pending
Level 3 · Early Human Research
Small human studies; delivery and outcome data remain limited.
Individual peptide
Appetite, glucose, metabolic, and energy-balance pathways under study.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Approved clinical use in fertility and endocrine testing.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Approved clinical use in fertility and endocrine medicine.
Individual peptide
Appetite, glucose, metabolic, and energy-balance pathways under study.
Evidence Review Pending
Level 3 · Early Human Research
Small early human studies of growth hormone and cardiac signaling.
Other research compound
Muscle signaling, performance, and post-exercise recovery pathways under study.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Recombinant growth hormone with approved clinical indications.
Other research compound
Appetite, glucose, metabolic, and energy-balance pathways under study.
Evidence Review Pending
Level 3 · Early Human Research
Limited early human data; mostly preclinical work.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Approved gonadotropin preparation used in fertility clinics.
Evidence Review Pending
Level 2 · Animal Research
Animal and cell studies of mitochondrial and neuroprotective signaling.
Other research compound
Skin, hair, pigmentation, collagen, and extracellular-matrix pathways under study.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Approved medical and dermatological injectable preparations.
Individual peptide
Muscle signaling, performance, and post-exercise recovery pathways under study.
Evidence Review Pending
Level 1 · Laboratory Research
Laboratory and cell-culture research reagent.
Evidence Review Pending
Level 3 · Early Human Research
Early human studies of growth hormone release and gut motility.
Evidence Review Pending
Level 4 · Controlled Human Studies
Controlled human studies of reproductive hormone signaling.
Evidence Review Pending
Level 2 · Animal Research
Animal and cell studies of inflammatory signaling.
Other research compound
Appetite, glucose, metabolic, and energy-balance pathways under study.
Evidence Review Pending
Level 4 · Controlled Human Studies
Multiple randomized trials across metabolic and exercise endpoints.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Long-standing regulatory approval in diabetes and obesity care.
Individual peptide
Gastrointestinal, mucosal, pancreatic, and digestive signaling under study.
Evidence Review Pending
Level 1 · Laboratory Research
Laboratory bioregulator work only.
Individual peptide
Immune signaling, host defense, and inflammatory-response pathways under study.
Evidence Review Pending
Level 3 · Early Human Research
Early human studies in wound healing and infection.
Individual peptide
Skin, hair, pigmentation, collagen, and extracellular-matrix pathways under study.
Evidence Review Pending
Level 4 · Controlled Human Studies
Controlled topical cosmetic trials in human skin.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Approved for weight management in China after phase 3 trials.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Approved as afamelanotide for erythropoietic protoporphyria.
Evidence Review Pending
Level 2 · Animal Research
Animal and uncontrolled use data; no approved human program.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Regulated sleep product with prescription approvals in several regions.
Individual peptide
Muscle signaling, performance, and post-exercise recovery pathways under study.
Evidence Review Pending
Level 1 · Laboratory Research
Cell and tissue studies of muscle repair signaling.
Evidence Review Pending
Level 2 · Animal Research
Animal and cell studies of mitochondrial signaling; human data minimal.
Individual peptide
Sleep architecture, relaxation, and circadian-signaling research.
Evidence Review Pending
Level 1 · Laboratory Research
Laboratory analog work; no independent human data.
Individual peptide
Cognition, mood, focus, and neural signaling pathways under study.
Evidence Review Pending
Level 2 · Animal Research
Analog of Selank; own data limited to laboratory and animal work.
Individual peptide
Cognition, mood, focus, and neural signaling pathways under study.
Evidence Review Pending
Level 2 · Animal Research
Analog of Semax; own data limited to laboratory and animal work.
Blend · 1 component
Researchers are studying this blend in relation to appetite signaling and glucose regulation.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Evidence Review Pending
Level 1 · Laboratory Research
Laboratory bioregulator work only.
Individual peptide
Cognition, mood, focus, and neural signaling pathways under study.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Approved obstetric medicine; other uses remain investigational.
Evidence Review Pending
Level 1 · Laboratory Research
Laboratory neurogenesis research only.
Evidence Review Pending
Level 2 · Animal Research
Animal and cell bioregulator studies from a limited research group.
Evidence Review Pending
Level 1 · Laboratory Research
Laboratory and early animal neuroscience research.
Individual peptide
Muscle signaling, performance, and post-exercise recovery pathways under study.
Evidence Review Pending
Level 1 · Laboratory Research
Cell and tissue studies; no published human data.
Evidence Review Pending
Level 2 · Animal Research
Animal and cell bioregulator studies from a limited research group.
Individual peptide
Cellular aging, senescence, resilience, and longevity-related pathways under study.
Evidence Review Pending
Level 1 · Laboratory Research
Cell-model cancer research only.
Evidence Review Pending
Level 2 · Animal Research
Animal and cell bioregulator studies from a limited research group.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Approved as bremelanotide for hypoactive sexual desire disorder.
Evidence Review Pending
Level 4 · Controlled Human Studies
Randomized phase 2/3 trials completed or underway; not yet approved.
Blend · 2 components
Research interest in this blend centres on energy balance and metabolic-rate pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Blend · 2 components
This blend is examined in studies of nutrient handling and body-composition pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Evidence Review Pending
Level 4 · Controlled Human Studies
Controlled anxiolytic trials in Russia; limited independent replication.
Blend · 2 components
Researchers are studying this blend in relation to neural signaling, focus, and mood pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Approved by major regulators for type 2 diabetes and weight management.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Registered for clinical use in Russia; limited evidence elsewhere.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Previously approved for growth hormone deficiency diagnosis and therapy.
Individual peptide
Skin, hair, pigmentation, collagen, and extracellular-matrix pathways under study.
Evidence Review Pending
Level 3 · Early Human Research
Small human cosmetic studies of topical application.
Individual peptide
Muscle signaling, performance, and post-exercise recovery pathways under study.
Evidence Review Pending
Level 4 · Controlled Human Studies
Randomized elamipretide trials in mitochondrial and cardiac disease.
Blend · 2 components
Research interest in this blend centres on energy balance and metabolic-rate pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Evidence Review Pending
Level 4 · Controlled Human Studies
Randomized phase 2/3 obesity and MASH trials; not yet approved.
Individual peptide
Muscle signaling, performance, and post-exercise recovery pathways under study.
Evidence Review Pending
Level 1 · Laboratory Research
Fragment studied in laboratory models only.
Individual peptide
Muscle signaling, performance, and post-exercise recovery pathways under study.
Evidence Review Pending
Level 1 · Laboratory Research
Fragment studied in laboratory models only.
Individual peptide
Muscle signaling, performance, and post-exercise recovery pathways under study.
Evidence Review Pending
Level 3 · Early Human Research
Early human trials of thymosin beta-4 in wound and eye care.
Individual peptide
Muscle signaling, performance, and post-exercise recovery pathways under study.
Evidence Review Pending
Level 1 · Laboratory Research
Laboratory-stage material with minimal published research.
Individual peptide
Muscle signaling, performance, and post-exercise recovery pathways under study.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Approved osteoporosis therapy with extensive clinical use.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Approved for HIV-associated lipodystrophy.
Blend · 2 components
This blend is examined in studies of nutrient handling and body-composition pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Evidence Review Pending
Level 1 · Laboratory Research
Laboratory bioregulator work only.
Individual peptide
Immune signaling, host defense, and inflammatory-response pathways under study.
Evidence Review Pending
Level 3 · Early Human Research
Small human immune studies, largely from a single research lineage.
Individual peptide
Immune signaling, host defense, and inflammatory-response pathways under study.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Registered immunomodulator in numerous countries.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Approved by major regulators for type 2 diabetes and weight management.
Evidence Review Pending
Level 1 · Laboratory Research
Laboratory bioregulator work only.
Individual peptide
Immune signaling, host defense, and inflammatory-response pathways under study.
Evidence Review Pending
Level 2 · Animal Research
Animal and cell bioregulator studies from a limited research group.
Evidence Review Pending
Level 4 · Controlled Human Studies
Controlled aviptadil trials in respiratory and pulmonary conditions.
Other research compound
Mitochondrial function, cellular energy, and metabolic resilience under study.
Evidence Review Pending
Level 5 · Regulatory Review or Established Clinical Use
Established clinical use for deficiency correction.
Evidence Review Pending
Level 2 · Animal Research
Rodent metabolic studies; no published human trials.
0 peptides selected
Select up to 6 peptides to compare.